Impact of extrafine formulation single-inhaler triple therapy on health-related quality of life after three months of treatment in patients with asthma: the TriMaximize study

被引：0
|
作者：
Koczulla, Rembert [1 ,2 ]
Akyildiz, Berktan [3 ]
Ulrik, Charlotte Suppli [4 ]
Nachtigall, Detlef [3 ]
Russell, Richard [5 ]
Bogoevska, Valentina [3 ]
Pohl, Wolfgang [6 ]
Borucki, Tanja [3 ]
Martini, Maurice-Dominique [3 ]
Gessner, Christian [7 ]
机构：
[1] Philipps Univ Marburg, Dept Pulm Med & Rehabil, Marburg, Germany
[2] German Ctr Lung Res, Marburg, Germany
[3] Chiesi GmbH Hamburg, Hamburg, Germany
[4] Copenhagen Univ Hosp Hvidovre, Dept Pulm Med, Hvidovre, Denmark
[5] Univ Oxford, Oxford, England
[6] Vienna Healthcare Grp, Karl Landsteiner Inst Clin & Expt Pneumol, Clin Hietzing, Vienna, Austria
[7] Pneumol Praxis Leipzig, Leipzig, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2374
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Change in asthma control after three months of treatment with extrafine formulation singleinhaler triple therapy in patients with asthma: the TriMaximize study
    Greulich, Timm
    Akyildiz, Berktan
    Pohl, Wolfgang
    Nachtigall, Detlef
    Russell, Richard
    Bogoevska, Valentina
    Ulrik, Charlotte Suppli
    Slawinska, Renata
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [12] Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study
    Gessner, C.
    Akyildiz, B.
    Cesarz, K.
    Sauer, A.
    Bogoevska, V
    Criee, P. C.
    PNEUMOLOGIE, 2022, 76 : S7 - S8
  • [13] Exacerbation reduction and improved quality of life in asthma with extrafine formulation single-inhaler triple therapy (efSITT): six-month results of the TriMaximize Study
    Trinkmann, Frederik
    Bogoevska, Valentina
    Nachtigall, Detlef
    Russell, Richard
    Ulrik, Charlotte Suppli
    Pohl, Wolfgang
    Plaza, Vicente
    Bourdin, Arnaud
    Fritz, Celina
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [14] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
    Tabberer, Maggie
    Jones, C. Elaine
    Kilbride, Sally
    Halpin, David M. G.
    Lomas, David A.
    Pascoe, Steven
    Singh, Dave
    Wise, Robert A.
    Criner, Gerard J.
    Lange, Peter
    Dransfield, Mark T.
    Han, Meilan K.
    Martinez, Fernando J.
    Kaisermann, Morrys C.
    Lipson, David A.
    ADVANCES IN THERAPY, 2020, 37 (09) : 3775 - 3790
  • [15] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
    Maggie Tabberer
    C. Elaine Jones
    Sally Kilbride
    David M. G. Halpin
    David A. Lomas
    Steven Pascoe
    Dave Singh
    Robert A. Wise
    Gerard J. Criner
    Peter Lange
    Mark T. Dransfield
    MeiLan K. Han
    Fernando J. Martinez
    Morrys C. Kaisermann
    David A. Lipson
    Advances in Therapy, 2020, 37 : 3775 - 3790
  • [16] Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
    Maggie Tabberer
    C. Elaine Jones
    Sally Kilbride
    David M. G. Halpin
    David A. Lomas
    Steven Pascoe
    Dave Singh
    Robert A. Wise
    Gerard J. Criner
    Peter Lange
    Mark T. Dransfield
    MeiLan K. Han
    Fernando J. Martinez
    Morrys C. Kaisermann
    David A. Lipson
    Advances in Therapy, 2022, 39 : 1446 - 1446
  • [17] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Koczulla, A.
    Akyildiz, B.
    Slawinska, R.
    Martini, M.
    Gessner, C.
    PNEUMOLOGIE, 2023, 77 : S35 - S35
  • [18] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [19] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After 1 Year: TriMaximize-A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Voves, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Nevels, R.
    Pohl, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S541 - S541
  • [20] Treatment with extrafine formulation single-inhaler triple therapy improves disease control and adherence in patients with asthma - a 3-month interim analysis from the TriMaximize UK study
    Richards, J.
    Rangwani, N.
    Russell, R.
    THORAX, 2023, 78 (SUPPL_4) : A83 - A84
12345